Microsphere as a novel strategy for the long-term use of corticosteroids in asthma patients during the COVID-19 Pandemic

The use of corticosteroids during the (Coronavirus Disease 2019) COVID-19 has become a new concern. Corticosteroids are main therapy in asthmatic patients with anti-inflammatory and immunosuppressant effects. Patients need for long-term corticosteroids, such as asthma patients, aware risk from infection obtained by side effect corticosteroid use. A Recent study innovated drug delivery agent, called Microsphere that can specify targeted therapy. This may potentially increase treatment efficacy lesser Here we review uses delivering corticosteroids. Additional studies warranted to support Microspheres novel pandemic.